D.E. Shaw & Co
ZLAB icon

D.E. Shaw & Co’s Zai Lab ZLAB Stock Holding History

D.E. Shaw & Co’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-69,000
Closed -$1.67M – 4961
2024
Q3 		$1.67M Hold
69,000
– – ﹤0.01% 2856
2024
Q2 		$1.2M Buy
69,000
+37,000
+116% +$651K ﹤0.01% 3065
2024
Q1 		$513K Buy
+32,000
New +$674K ﹤0.01% 3476
2021
Q4 		– Sell
-2,500
Closed -$263K – 5761
2021
Q3 		$263K Hold
2,500
– – ﹤0.01% 4435
2021
Q2 		$442K Hold
2,500
– – ﹤0.01% 4098
2021
Q1 		$334K Buy
+2,500
New +$387K ﹤0.01% 3667

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co's ZLAB Position: Q2 2026 in Review

D.E. Shaw & Co increased its Zai Lab (ZLAB) stake by 123% in Q2 2026, buying an estimated $1.54M and bringing the position to 141,158 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

D.E. Shaw & Co first reported a position in ZLAB in Q4 2017 and has held it in 30 quarters since. The position peaked at $30.7M in Q4 2020. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • D.E. Shaw & Co held 141,158 shares of Zai Lab worth $2.68M as of Q2 2026.
  • D.E. Shaw & Co bought 77,915 Zai Lab shares in Q2 2026, an estimated $1.54M.
  • Zai Lab made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2949 holding.
  • D.E. Shaw & Co first reported a position in Zai Lab in Q4 2017 and has held it in 30 quarters since.
  • D.E. Shaw & Co's Zai Lab position peaked at $30.7M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.